Julia Gregory
Président chez NURIX THERAPEUTICS, INC.
Fortune : 989 129 $ au 30/04/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Chris Cargill | M | 40 | 7 ans | |
Vladimir Coric | M | 53 | 9 ans | |
Gregory Bailey | M | 68 | 10 ans | |
John Childs | M | 81 | 10 ans | |
Michael Heffernan | M | 59 | 4 ans | |
Irina Antonijevic | M | 59 | 2 ans | |
Robert Hugin | M | 69 | 4 ans | |
George Clark | M | - | 5 ans | |
Clifford Bechtold | M | - | 7 ans | |
David Lacey | M | 71 | 8 ans | |
Douglas G. Gray | M | - | - | |
Christine Ring | M | 59 | 5 ans | |
Samuel Barker | M | 81 | 24 ans | |
Kirk Dornbush | M | - |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 21 ans |
Amit Chunilal Nathwani | M | 64 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 ans |
Kimberly Gentile | F | 56 | 9 ans | |
Andrew Hall | M | - | 4 ans | |
Michael P. Bailey | M | 58 | 4 ans | |
Matthew Buten | M | 62 | 3 ans | |
Jason Daniel Kantor | M | - | 4 ans | |
Ray Debbane | M | 69 | 17 ans | |
Arthur Sands | M | 62 | 10 ans | |
Michiel C. McCarty | M | 72 |
M.M. Dillon & Co. LLC
M.M. Dillon & Co. LLC Investment Banks/BrokersFinance M.M. Dillon & Co. operates as an investment banking firm. It offers capital raising and advisory services across all forms of securities. The firm also provides mergers and acquisition, capital raising, private placement, capital restructuring, public equity offering, and transaction advisory services. It provides services to the healthcare, technology, media & telecom, industrial, energy, clean tech and gaming industries. The company was founded by George W. Bickerstaff III in 2009 and is headquartered in Greenwich, CT.
Dillon, Read & Co., Inc.
| 28 ans |
Kishan Mehta | M | 38 | 3 ans | |
Delphine Davan | F | - | 5 ans | |
Edward Saltzman | M | 69 | 2 ans | |
Michael Kalos | M | 62 | 3 ans | |
David Saunders | M | - | 4 ans | |
Jennifer Porcelli | F | - | 2 ans | |
Saman Maleki | M | - | 2 ans | |
Irfan Qureshi | M | - | - | |
Paloma Moraleda | F | - | 2 ans | |
Markus Warmuth | M | 53 | 6 ans | |
Megan M. Dow | M | - | 4 ans | |
Judith Swain | M | 75 | 17 ans | |
Judith Reinsdorf | F | 60 | 3 ans | |
George Bickerstaff | M | 68 |
M.M. Dillon & Co. LLC
M.M. Dillon & Co. LLC Investment Banks/BrokersFinance M.M. Dillon & Co. operates as an investment banking firm. It offers capital raising and advisory services across all forms of securities. The firm also provides mergers and acquisition, capital raising, private placement, capital restructuring, public equity offering, and transaction advisory services. It provides services to the healthcare, technology, media & telecom, industrial, energy, clean tech and gaming industries. The company was founded by George W. Bickerstaff III in 2009 and is headquartered in Greenwich, CT. | 19 ans |
Paul Silva | M | 58 | 3 ans | |
Robert Lefkowitz | M | 80 | 23 ans | |
William Greene | M | - |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 10 ans |
Christopher Sobecki | M | 65 | 17 ans | |
Philippe Amouyal | M | 65 | 17 ans | |
David Roblin | M | 57 | 6 ans | |
Gastón Ortega | M | - | 2 ans | |
Brian Crum | M | 51 | 23 ans | |
Kuniaki Kaga | M | 72 | 6 ans | |
Kyle Kuvalanka | M | 56 | 3 ans | |
Noriaki Nagai | M | 66 | 5 ans | |
Lori Kunkel | M | 66 | 5 ans | |
Chris Hollowood | M | 50 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 ans |
Jeremy Graff | M | - | 3 ans | |
Lisa Stocking | F | - | - | |
Chris Barrett | M | - | - | |
Jeffrey Chodakewitz | M | 68 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
Todd Foley | M | 52 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 10 ans |
K. Hirth | M | 72 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 9 ans |
Jon Blaskovich | M | - | - | |
Martin Andrews | M | 61 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
Maryellen McQuade | F | - | - | |
Gwenn Hansen | M | 53 | 9 ans | |
Colin Love | M | 65 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
Melissa Beiner | M | - | - | |
Caroline Dircks | M | - | 4 ans | |
Shabnam Kazmi | F | - | 1 ans | |
Shuai Li | M | - | 7 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Messinger | M | 49 | 22 ans | |
Aron M. Knickerbocker | M | 54 | 10 ans | |
Roger Pomerantz | M | 67 | 9 ans | |
Declan Doogan | M | 72 | 14 ans | |
Robert Nowinski | M | - | 5 ans | |
Steven Gilman | M | 71 | 8 ans | |
Timothy Kutzkey | M | 49 | 10 ans | |
Peter Bains | M | 65 | 8 ans | |
Frederic Ors | M | 50 | 6 ans | |
Elyse Stock | M | 66 | 5 ans | |
Albert Scardino | M | 76 | 10 ans | |
Francis Sarena | M | 53 | 11 ans | |
Gregg Stephen Sando | M | - |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | 12 ans |
Kenny S. Frazier | M | - | - | |
David Low | M | 65 | 9 ans | |
Barry Kappel | M | 48 | 6 ans | |
Anthony Price | M | - | 8 ans | |
James Engelhart | M | 60 | 5 ans | |
Marc Jasmin | M | - | - | |
Sheng Da Zan | M | 61 | - | |
John P. Birkelund | M | 94 |
Dillon, Read & Co., Inc.
| 16 ans |
Robert Tjian | M | 74 | 4 ans | |
James F. Tessmer | M | 64 | 20 ans | |
Franklin Berger | M | 74 | 11 ans | |
Wayne Pisano | M | 69 | 10 ans | |
Alfred A. Smithers | M | - | 4 ans | |
Jeffrey Tong | M | 48 | 4 ans | |
Eric Aguiar | M | 62 | 4 ans | |
Alan Nies | M | 86 | 20 ans | |
Alan Main | M | 69 | - | |
Peder Jensen | M | 69 | 10 ans | |
David Scheinberg | M | 68 | 6 ans | |
Steven Alan Tragash | M | 77 | 3 ans | |
Frank Palantoni | M | 66 | 19 ans | |
Takuya Fujii | M | 78 | 12 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 66 | 66,00% |
Canada | 14 | 14,00% |
Japon | 7 | 7,00% |
Royaume-Uni | 6 | 6,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Julia Gregory
- Réseau Personnel